- Home
- AARD vs RVSB Comparison
AARD vs RVSB Comparison
Compare AARD & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- RVSB
- Stock Information
- Founded
- AARD 2017
- RVSB 1923
- Country
- AARD United States
- RVSB United States
- Employees
- AARD N/A
- RVSB N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- RVSB Savings Institutions
- Sector
- AARD Health Care
- RVSB Finance
- Exchange
- AARD Nasdaq
- RVSB Nasdaq
- Market Cap
- AARD 154.9M
- RVSB 124.0M
- IPO Year
- AARD 2025
- RVSB 1993
- Fundamental
- Price
- AARD $10.14
- RVSB $6.12
- Analyst Decision
- AARD Strong Buy
- RVSB Buy
- Analyst Count
- AARD 4
- RVSB 1
- Target Price
- AARD $31.50
- RVSB $7.00
- AVG Volume (30 Days)
- AARD 69.4K
- RVSB 169.2K
- Earning Date
- AARD 01-01-0001
- RVSB 04-29-2025
- Dividend Yield
- AARD N/A
- RVSB 1.32%
- EPS Growth
- AARD N/A
- RVSB 27.97
- EPS
- AARD N/A
- RVSB 0.23
- Revenue
- AARD N/A
- RVSB $50,500,000.00
- Revenue This Year
- AARD N/A
- RVSB $8.46
- Revenue Next Year
- AARD N/A
- RVSB $11.73
- P/E Ratio
- AARD N/A
- RVSB $26.35
- Revenue Growth
- AARD N/A
- RVSB 4.49
- 52 Week Low
- AARD $4.88
- RVSB $3.30
- 52 Week High
- AARD $19.58
- RVSB $6.38
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- RVSB 54.85
- Support Level
- AARD N/A
- RVSB $6.00
- Resistance Level
- AARD N/A
- RVSB $6.30
- Average True Range (ATR)
- AARD 0.00
- RVSB 0.19
- MACD
- AARD 0.00
- RVSB -0.02
- Stochastic Oscillator
- AARD 0.00
- RVSB 27.14
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.